Low hepatic cytochrome P450 3A activity is a risk for corticosteroid-induced osteonecrosis

被引：8
|
作者：
Nafziger, A. N. [1 ]
Bertino, J. S., Jr. [1 ]
机构：
[1] Ordway Res Inst, Inst Drug Dev Ctr, Albany, NY USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2007年 / 82卷 / 04期
关键词：
D O I：
10.1038/sj.clpt.6100105
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：379 / 379
页数：1
相关论文
共 50 条
  • [41] Concurrent Assessment of Hepatic and Intestinal Cytochrome P450 3A Activities Using Deuterated Alfentanil
    Kharasch, E. D.
    Vangveravong, S.
    Buck, N.
    London, A.
    Kim, T.
    Blood, J.
    Mach, R. H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (04) : 562 - 570
  • [42] Cytochrome P450 3A pharmacogenetics: the road that needs traveled
    Flockhart, DA
    Rae, JM
    PHARMACOGENOMICS JOURNAL, 2003, 3 (01): : 3 - 5
  • [43] EFFECT OF CANNABIDIOL (CBD) ON CYTOCHROME P450 3A IN THE MOUSE
    BORNHEIM, LM
    EVERHART, ET
    LI, J
    FASEB JOURNAL, 1993, 7 (03): : A265 - A265
  • [44] Estrogen regulation of the cytochrome P450 3A subfamily in humans
    Williams, ET
    Leyk, M
    Wrighton, SA
    Davies, PJA
    Loose, DS
    Shipley, GL
    Strobel, HW
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 311 (02): : 728 - 735
  • [45] Role of transgene expression on hepatic cytochrome P450 3A and 2C11
    Callahan, SM
    Lu, SK
    Ming, X
    Brunner, LJ
    Croyle, MA
    MOLECULAR THERAPY, 2003, 7 (05) : S58 - S58
  • [46] The effect of oral pleconaril on hepatic cytochrome P450 3A activity in healthy adults using intravenous midazolam as a probe
    Ma, JD
    Nafziger, AN
    Rhodes, G
    Liu, SY
    Gartung, AM
    Bertino, JS
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (01): : 103 - 108
  • [47] Cytochrome P450 3A pharmacogenetics: the road that needs traveled
    D A Flockhart
    J M Rae
    The Pharmacogenomics Journal, 2003, 3 : 3 - 5
  • [48] How important is intestinal cytochrome P450 3A metabolism?
    van Herwaarden, Antonius E.
    van Waterschoot, Robert A. B.
    Schinkel, Alfred H.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2009, 30 (05) : 223 - 227
  • [49] Cytochrome P450 3A: Genetic polymorphisms and interethnic differences
    Krishna, DR
    Shekar, MS
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2005, 27 (08): : 559 - 567
  • [50] In vitro and in vivo Inhibitory Effects of Glycyrrhetinic Acid on Cytochrome P450 3A Activity
    Li, Hai Yun
    Xu, Wen
    Su, Juan
    Zhang, Xi
    Hu, Li Wei
    Zhang, Wei Dong
    PHARMACOLOGY, 2010, 86 (5-6) : 287 - 292
12345